Vincent J. Angotti - 13 Dec 2023 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role
Chief Executive Officer, Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
TLPH
Transactions as of
13 Dec 2023
Net transactions value
+$7,268
Form type
4
Filing time
14 Dec 2023, 08:11:04 UTC
Previous filing
11 Sep 2023
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Purchase $7,268 +10,000 +11% $0.7268 101,805 13 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.7198 to $0.73 on December 13, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.